These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33651117)

  • 21. Surveillance Study of Acute Neurological Manifestations among 439 Egyptian Patients with COVID-19 in Assiut and Aswan University Hospitals.
    Khedr EM; Abo-Elfetoh N; Deaf E; Hassan HM; Amin MT; Soliman RK; Attia AA; Zarzour AA; Zain M; Mohamed-Hussein A; Hashem MK; Hassany SM; Aly A; Shoyb A; Saber M
    Neuroepidemiology; 2021; 55(2):109-118. PubMed ID: 33631765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Potential Role of COVID-19 in the Pathogenesis of Multiple Sclerosis-A Preliminary Report.
    Satheesh NJ; Salloum-Asfar S; Abdulla SA
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encephalopathy in patients with COVID-19: A review.
    Garg RK; Paliwal VK; Gupta A
    J Med Virol; 2021 Jan; 93(1):206-222. PubMed ID: 32558956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2-Related Encephalitis: The ENCOVID Multicenter Study.
    Pilotto A; Masciocchi S; Volonghi I; Crabbio M; Magni E; De Giuli V; Caprioli F; Rifino N; Sessa M; Gennuso M; Cotelli MS; Turla M; Balducci U; Mariotto S; Ferrari S; Ciccone A; Fiacco F; Imarisio A; Risi B; Benussi A; Premi E; Focà E; Caccuri F; Leonardi M; Gasparotti R; Castelli F; Zanusso G; Pezzini A; Padovani A;
    J Infect Dis; 2021 Jan; 223(1):28-37. PubMed ID: 32986824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
    McGowan EM; Haddadi N; Nassif NT; Lin Y
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2-Associated Acute Hemorrhagic, Necrotizing Encephalitis (AHNE) Presenting with Cognitive Impairment in a 44-Year-Old Woman without Comorbidities: A Case Report.
    Ghosh R; Dubey S; Finsterer J; Chatterjee S; Ray BK
    Am J Case Rep; 2020 Aug; 21():e925641. PubMed ID: 32799213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed presentation of postinfectious encephalitis associated with SARS-CoV-2 infection: a case report.
    Gunawardhana C; Nanayakkara G; Gamage D; Withanage I; Bandara M; Siriwimala C; Senaratne N; Chang T
    Neurol Sci; 2021 Sep; 42(9):3527-3530. PubMed ID: 34138387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 Registry.
    Abenza Abildúa MJ; Atienza S; Carvalho Monteiro G; Erro Aguirre ME; Imaz Aguayo L; Freire Álvarez E; García-Azorín D; Gil-Olarte Montesinos I; Lara Lezama LB; Navarro Pérez MP; Pérez Sánchez JR; Romero Delgado F; Serrano Serrano B; Villarreal Vitorica E; Ezpeleta Echávarri D
    Neurologia (Engl Ed); 2021 Mar; 36(2):127-134. PubMed ID: 33549369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.
    Keyhanian K; Umeton RP; Mohit B; Davoudi V; Hajighasemi F; Ghasemi M
    J Neuroimmunol; 2020 Nov; 350():577436. PubMed ID: 33212316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19: dealing with a potential risk factor for chronic neurological disorders.
    Schirinzi T; Landi D; Liguori C
    J Neurol; 2021 Apr; 268(4):1171-1178. PubMed ID: 32852580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Encephalitis following COVID-19 disease].
    Varannai L; Magyar Z; Baranyai B; Ajzner É; Czurkó M
    Ideggyogy Sz; 2021 Jul; 74(7-08):277-285. PubMed ID: 34370409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious and immune-mediated central nervous system disease in 48 COVID-19 patients.
    Finsterer J; Scorza FA
    J Clin Neurosci; 2021 Aug; 90():140-143. PubMed ID: 34275539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.
    Bhaskar S; Sinha A; Banach M; Mittoo S; Weissert R; Kass JS; Rajagopal S; Pai AR; Kutty S
    Front Immunol; 2020; 11():1648. PubMed ID: 32754159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presentations and mechanisms of CNS disorders related to COVID-19.
    Bodro M; Compta Y; Sánchez-Valle R
    Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):. PubMed ID: 33310765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: a review.
    Dadkhah M; Talei S; Doostkamel D; Molaei S; Rezaei N
    Rev Neurosci; 2022 Jan; 33(1):79-92. PubMed ID: 34087964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 Morbidity in the CNS and the Aged Brain Specific Vulnerability.
    Casoli T
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 infection and seizures: the perfect storm.
    Tsai C; Wilson SE; Rubinos C
    J Integr Neurosci; 2022 Jun; 21(4):115. PubMed ID: 35864766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.
    Román GC; Spencer PS; Reis J; Buguet A; Faris MEA; Katrak SM; Láinez M; Medina MT; Meshram C; Mizusawa H; Öztürk S; Wasay M;
    J Neurol Sci; 2020 Jul; 414():116884. PubMed ID: 32464367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurological Complications of the COVID-19 Pandemic: What Have We Got So Far?
    Bandeira IP; Schlindwein MAM; Breis LC; Peron JPS; Gonçalves MVM
    Adv Exp Med Biol; 2021; 1321():21-31. PubMed ID: 33656710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
    Baig AM
    ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.